Answers are grounded in this paper and cite their sources.
Tunicamycin, an inhibitor of glycosylation, was used to examine the role of carbohydrate moieties of glycoproteins involved in recognition of Simian virus 40 (SV40)-transformed cells by cytotoxic T lymphocytes (CTL). Tunicamycin treatment renders such cells refractory to lysis by H-2 restricted, SV40-specific CTL as well as by allogeneic CTL directed only against H-2 antigens. Treated cells are no longer susceptible to lysis by anti-H-2 antisera and complement, nor are they stained by monoclonal anti-H-2 antibodies in an indirect immunofluorescence assay. No accumulation of H-2 proteins was detected in immunoprecipitates from cells labeled with [35S]methionine in the presence of tunicamycin. It is concluded that tunicamycin prevents the expression of H-2 glycoproteins in these cells, perhaps due to accelerated degradation of the unglycosylated molecules.
No takes yet. Share an insight, caveat, or question.
Swaminathan et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: